BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li C, Wu MY, Liang YR, Wu XY. Correlation between expression of human telomerase subunits and telomerase activity in esophageal squamous cell carcinoma. World J Gastroenterol 2003; 9(11): 2395-2399 [PMID: 14606063 DOI: 10.3748/wjg.v9.i11.2395]
URL: https://www.wjgnet.com/1007-9327/full/v9/i11/2395.htm
Number Citing Articles
1
Mahendar Porika, Radhika Tippani, Anwar Mohammad, Sekhar R Bollam, Sree D Panuganti, Sadanandam Abbagani. Evaluation of Serum Human Telomerase Reverse Transcriptase as a Novel Marker for Cervical CancerThe International Journal of Biological Markers 2011; 26(1): 22 doi: 10.5301/JBM.2011.6352
2
Yujuan Kang, Lin Wan, Qin Wang, Yanling Yin, Jiena Liu, Lei Liu, Hao Wu, Lei Zhang, Xin Zhang, Shouping Xu, Da Pang. RETRACTED ARTICLE: Long noncoding RNA SNHG1 promotes TERT expression by sponging miR-18b-5p in breast cancerCell & Bioscience 2021; 11(1) doi: 10.1186/s13578-021-00675-5
3
Ana Pestana, Rui Batista, Ricardo Celestino, Sule Canberk, Manuel Sobrinho-Simões, Paula Soares. Comprehensive Assessment of TERT mRNA Expression across a Large Cohort of Benign and Malignant Thyroid TumoursCancers 2020; 12(7): 1846 doi: 10.3390/cancers12071846
4
Utpal Ghosh, Nitai P. Bhattacharyya. Benzamide and 4‐amino 1,8 naphthalimide treatment inhibit telomerase activity by down‐regulating the expression of telomerase associated protein and inhibiting the poly(ADP‐ribosyl)ation of telomerase reverse transcriptase in cultured cellsThe FEBS Journal 2005; 272(16): 4237 doi: 10.1111/j.1742-4658.2005.04837.x
5
M.L. McCabe, Z. Dlamini. The molecular mechanisms of oesophageal cancerInternational Immunopharmacology 2005; 5(7-8): 1113 doi: 10.1016/j.intimp.2004.11.017
6
Laura Dioni, Mirjam Hoxha, Francesco Nordio, Matteo Bonzini, Letizia Tarantini, Benedetta Albetti, Alice Savarese, Joel Schwartz, Pier Alberto Bertazzi, Pietro Apostoli, Lifang Hou, Andrea Baccarelli. Effects of Short-Term Exposure to Inhalable Particulate Matter on Telomere Length, Telomerase Expression, and Telomerase Methylation in Steel WorkersEnvironmental Health Perspectives 2011; 119(5): 622 doi: 10.1289/ehp.1002486
7
Brenna M. McGruder, Donald H. Atha, Wendy Wang, Konrad Huppi, Wen-Qiang Wei, Christian C. Abnet, You-Lin Qiao, Sanford M. Dawsey, Philip R. Taylor, John P. Jakupciak. Real-time telomerase assay of less-invasively collected esophageal cell samplesCancer Letters 2006; 244(1): 91 doi: 10.1016/j.canlet.2005.12.012
8
Andrew C. Brane, Trygve O. Tollefsbol. Targeting Telomeres and Telomerase: Studies in Aging and Disease Utilizing CRISPR/Cas9 TechnologyCells 2019; 8(2): 186 doi: 10.3390/cells8020186
9
Meenu Jain, Shaleen Kumar, Punita Lal, Anu Tiwari, Uday C. Ghoshal, Balraj Mittal. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancerCancer Detection and Prevention 2007; 31(3): 225 doi: 10.1016/j.cdp.2007.04.005
10
Christina Loukopoulou, Taxiarchis Nikolouzakis, Ioannis Koliarakis, Elena Vakonaki, John Tsiaoussis. Telomere Length and Telomerase Activity as Potential Biomarkers for Gastrointestinal CancerCancers 2024; 16(19): 3370 doi: 10.3390/cancers16193370
11
Victoria Gonzalo, Anna Petit, Sergi Castellví-Bel, Maria Pellisé, Jenifer Muñoz, Carme Piñol, Francisco Rodríguez-Moranta, Joan Clofent, Francesc Balaguer, M. Dolores Giráldez, Teresa Ocaña, Anna Serradesanferm, Jaume Grau, Josep M. Reñé, Julián Panés, Antoni Castells. Telomerase mRNA expression and immunohistochemical detection as a biomarker of malignant transformation in patients with inflammatory bowel diseaseGastroenterología y Hepatología 2010; 33(4): 288 doi: 10.1016/j.gastrohep.2009.12.011
12
Mahendar Porika, Radhika Tippani, Sekhar R. Bollam, Sree Divya Panuganti, Christopher Thamidala, Sadanandam Abbagani. Serum human telomerase reverse transcriptase: a novel biomarker for breast cancer diagnosisInternational Journal of Clinical Oncology 2011; 16(6): 617 doi: 10.1007/s10147-011-0230-6
13
Liang Liu, Serene Lai, Lucy G. Andrews, Trygve O. Tollefsbol. Genetic and epigenetic modulation of telomerase activity in development and diseaseGene 2004; 340(1): 1 doi: 10.1016/j.gene.2004.06.011
14
Yun-Feng Wang, Ke-Jian Guo, Bei-Ting Huang, Yong Liu, Xiao-Yun Tang, Jian-Jun Zhang, Qiang Xia. Inhibitory effects of antisense phosphorothioate oligodeoxynucleotides on pancreatic cancer cell Bxpc-3 telomerase activity and cell growth <italic>in vitro</italic>World Journal of Gastroenterology 2006; 12(25): 4004-4008 doi: 10.3748/wjg.v12.i25.4004
15
Kayla A. Lewis, Trygve O. Tollefsbol. Regulation of the Telomerase Reverse Transcriptase Subunit through Epigenetic MechanismsFrontiers in Genetics 2016; 7 doi: 10.3389/fgene.2016.00083
16
Ana Pestana, João Vinagre, Manuel Sobrinho-Simões, Paula Soares. TERT biology and function in cancer: beyond immortalisationJournal of Molecular Endocrinology 2017; 58(2): R129 doi: 10.1530/JME-16-0195
17
Serene R. Lai, Amanda P. Cunningham, Vu Q. Huynh, Lucy G. Andrews, Trygve O. Tollefsbol. Evidence of extra-telomeric effects of hTERT and its regulation involving a feedback loopExperimental Cell Research 2007; 313(2): 322 doi: 10.1016/j.yexcr.2006.10.014
18
Mohamed JEMF Mabruk, Cathal O’Flatharta. Telomerase: is it the future diagnostic and prognostic tool in human cancer?Expert Review of Molecular Diagnostics 2005; 5(6): 907 doi: 10.1586/14737159.5.6.907
19
Hye-Ran Kim, Choong-Won Seo, Keunje Yoo, Sang Jun Han, Jongwan Kim. Yes-associated protein 1 as a prognostic biomarker and its correlation with telomerase in various cancersOsong Public Health and Research Perspectives 2021; 12(5): 324 doi: 10.24171/j.phrp.2021.0207
20
Haoli Wang, Jianwen Zhou, Qiong He, Yu Dong, Yanhui Liu. Azidothymidine inhibits cell growth and telomerase activity and induces DNA damage in human esophageal cancerMolecular Medicine Reports 2017; 15(6): 4055 doi: 10.3892/mmr.2017.6549